BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32205469)

  • 1. Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease.
    Akçimen F; Martins S; Liao C; Bourassa CV; Catoire H; Nicholson GA; Riess O; Raposo M; França MC; Vasconcelos J; Lima M; Lopes-Cendes I; Saraiva-Pereira ML; Jardim LB; Sequeiros J; Dion PA; Rouleau GA
    Aging (Albany NY); 2020 Mar; 12(6):4742-4756. PubMed ID: 32205469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
    Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population.
    Peng H; Wang C; Chen Z; Sun Z; Jiao B; Li K; Huang F; Hou X; Wang J; Shen L; Xia K; Tang B; Jiang H
    Neurobiol Aging; 2014 Sep; 35(9):2179.e15-8. PubMed ID: 24746364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients.
    Long Z; Chen Z; Wang C; Huang F; Peng H; Hou X; Ding D; Ye W; Wang J; Pan Q; Li J; Xia K; Tang B; Ashizawa T; Jiang H
    PLoS One; 2015; 10(2):e0117488. PubMed ID: 25689313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yemenite-Jewish families with Machado-Joseph disease (MJD/SCA3) share a recent common ancestor.
    Sharony R; Martins S; Costa IPD; Zaltzman R; Amorim A; Sequeiros J; Gordon CR
    Eur J Hum Genet; 2019 Nov; 27(11):1731-1737. PubMed ID: 31189928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.
    Zhou Q; Ni W; Dong Y; Wang N; Gan SR; Wu ZY
    PLoS One; 2014; 9(11):e111356. PubMed ID: 25369462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machado Joseph-Disease Is Rare in the Peruvian Population.
    Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
    Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.
    Bettencourt C; Santos C; Coutinho P; Rizzu P; Vasconcelos J; Kay T; Cymbron T; Raposo M; Heutink P; Lima M
    BMC Neurol; 2011 Oct; 11():131. PubMed ID: 22023810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
    Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3.
    Leotti VB; de Vries JJ; Oliveira CM; de Mattos EP; Te Meerman GJ; Brunt ER; Kampinga HH; Jardim LB; Verbeek DS
    Ann Neurol; 2021 Jan; 89(1):66-73. PubMed ID: 32978817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Variation in ATXN3 (Ataxin-3) 3'UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3.
    Melo ARV; Raposo M; Ventura M; Martins S; Pavão S; Alonso I; Bettencourt C; Lima M
    Cerebellum; 2023 Feb; 22(1):37-45. PubMed ID: 35034258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
    Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
    Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
    Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA haplogroups and age at onset of Machado-Joseph disease/spinocerebellar ataxia type 3: a study in patients from multiple populations.
    Ramos A; Planchat M; Vieira Melo AR; Raposo M; Shamim U; Suroliya V; Srivastava AK; Faruq M; Morino H; Ohsawa R; Kawakami H; Bannach Jardim L; Saraiva-Pereira ML; Vasconcelos J; Santos C; Lima M
    Eur J Neurol; 2019 Mar; 26(3):506-512. PubMed ID: 30414314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spastic paraparesis as the first manifestation of Machado-Joseph disease: A case report and review of the literature.
    Lin HC; Chang YY; Chang KH; Chen YF; Lan MY
    Clin Neurol Neurosurg; 2018 Sep; 172():137-140. PubMed ID: 30007589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype.
    Martins AC; Rieck M; Leotti VB; Saraiva-Pereira ML; Jardim LB
    J Mol Neurosci; 2021 Sep; 71(9):1906-1913. PubMed ID: 34191270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin.
    de Mattos EP; Leotti VB; Soong BW; Raposo M; Lima M; Vasconcelos J; Fussiger H; Souza GN; Kersting N; Furtado GV; Saute JAM; Camey SA; Saraiva-Pereira ML; Jardim LB
    Eur J Neurol; 2019 Jan; 26(1):113-120. PubMed ID: 30125433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning Future Clinical Trials for Machado-Joseph Disease.
    Saute JAM; Jardim LB
    Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
    Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
    Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala.
    Martins S; Soong BW; Wong VC; Giunti P; Stevanin G; Ranum LP; Sasaki H; Riess O; Tsuji S; Coutinho P; Amorim A; Sequeiros J; Nicholson GA
    Arch Neurol; 2012 Jun; 69(6):746-51. PubMed ID: 22351852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.